A new imaging technique can monitor, in living mice, the HER2 protein found in above-normal amounts in many cases of breast cancer as well as some ovarian, prostate and lung cancers.
A new imaging technique can monitor, in living mice, the HER2 protein found in above-normal amounts in many cases of breast cancer as well as some ovarian, prostate and lung cancers. This new approach, once validated in mice and pending further experiments, could provide a real-time noninvasive method for identifying tumors in humans who express HER2 and who would be candidates for targeted therapy directed against this protein.
Vegetarians are 12 per cent less likely to develop cancer than meat eaters.
Vegetarians are 12 per cent less likely to develop cancer than meat eaters, according to new research published in the British Journal of Cancer.
In a study of more than 61,000 people, Cancer Research UK scientists from Oxford followed meat eaters and vegetarians for over 12 years, during which 3,350 of the participants were diagnosed with cancer.
They found that the risk of being diagnosed with cancers of the stomach, bladder and blood was lower in vegetarians than in meat eaters.
Specific variations or mutations in a particular can gene raise a man?s risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease.
Specific variations or mutations in a particular can gene raise a man?s risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease, according to new research by scientists at the National Institutes of Health. This is only the second gene to be identified that affects the risk of familial testicular cancer, and the first gene in a key biochemical pathway.
The researchers have developed a method with the potential to increase accuracy in detecting real cancer biomarkers that is highly reproducible across laboratories and a variety of instruments so that cancer can be caught in its earliest stages.
A team of researchers has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline. The researchers have developed a method with the potential to increase accuracy in detecting real cancer biomarkers that is highly reproducible across laboratories and a variety of instruments so that cancer can be caught in its earliest stages.
The editor of a leading cancer research journal has called for a global pooling of research knowledge in order to tackle the disease by finding cancer treatment. Cancer is set to become the world?s leading cause of death by the end of next year.
The Editor-in-Chief of Cancer Investigation, published by Informa Healthcare, has called for clarity, transparency and vision in the development and evaluation of better diagnostic, treatment and prevention options for cancer patients around the globe. Gary H. Lyman, MD, MPH, FRCP (Edin), has outlined the future of the fight against cancer in a detailed commentary piece, which focuses on comparative effectiveness research (CER) ? a process for identifying and synthesizing the totality of available evidence on the effectiveness, safety and overall value of competing clinical strategies.
Researchers have discovered a key to the function of a specific protein that helps control the levels of other critical proteins within cells, including a protein that suppresses the spread of cancer.
Researchers have discovered a key to the function of a specific protein that helps control the levels of other critical proteins within cells, including a protein that suppresses the spread of cancer. The new information about the mechanism of action of the protein, called gp78, may enable researchers to explore new types of therapies to prevent the spread of cancer. The study, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, was published in the June 26, 2009, issue of Molecular Cell.
Source:
National Institute of Allergy and Infectious Diseases
A panel of scientists including epidemiologists, oncologists and the World Wildlife Fund (WWF) has launched an awareness campaign on the dangers of poorly filtered drinking water for people suffering from cancer.
A panel of scientists including epidemiologists, oncologists and the World Wildlife Fund (WWF) has launched an awareness campaign on the dangers of poorly filtered drinking water for people suffering from cancer.
While tap water is generally of good quality (92% on average according to the Committee), the water of some rivers, however, is polluted by agricultural pesticides. These chemicals are bad for people in frail health, especially those suffering from cancer and receiving treatment.
Scientists' discovery of a cancer-causing gene ? the first in its family to be linked to cancer ? demonstrates how the panoramic view of genomics and the close-up perspective of molecular biology are needed to determine which genes are involved in cancer and which are mere bystanders.
Dana-Farber Cancer Institute scientists' discovery of a cancer-causing gene ? the first in its family to be linked to cancer ? demonstrates how the panoramic view of genomics and the close-up perspective of molecular biology are needed to determine which genes are involved in cancer and which are mere bystanders.
The findings are reported in the June 25 issue of the journal Nature.
As many as 15,000 people over 75 could be dying prematurely from cancer each year in the UK.
As many as 15,000 people over 75 could be dying prematurely from cancer each year in the UK, according to research presented today at the National Cancer Intelligience Network (NCIN) conference.
These premature deaths could be prevented if cancer mortality rates in the UK dropped to match countries in Europe and America which have the lowest rates.
The researchers from the North West Cancer Intelligence Service (NWCIS) in Manchester compared cancer death rates in the UK with Europe and America.
Nine in ten people with bowel cancer that is caught early will survive the disease.
Nine in ten people with bowel cancer that is caught early will survive the disease, according to new statistics. Experts believe this shows how vital it is for people with possible symptoms to get them checked out so that any cancer can be diagnosed as early as possible.
They also say that this highlights the importance of taking part in bowel cancer screening when invited. The latest figures are the first to be based on national statistics and are published by the National Cancer Intelligence Network (NCIN) and the Northern and Yorkshire Cancer Registry and Information Service (NYCRIS).
During this tough economy, the financial burden on cancer patients can be especially trying. Balancing everyday expenses with care-related costs and, for some, income loss, can result in significant financial stress.
During this tough economy, the financial burden on cancer patients can be especially trying. Balancing everyday expenses with care-related costs and, for some, income loss, can result in significant financial stress.
Recognizing these challenges, Dana-Farber Cancer Institute has teamed up with the Financial Planning Association of Massachusetts to offer free, individual financial coaching services to its patients and their caregivers. It is one of the nation's first such programs.
Researchers have found a new way to study how genes function in living organisms, and their approach could substantially cut the time and costs that drug makers spend in searching for potential targets for new cancer therapies.
Researchers at the University of Virginia Health System have found a new way to study how genes function in living organisms, and their approach could substantially cut the time and costs that drug makers spend in searching for potential targets for new cancer therapies.
Men are almost 40 per cent more likely than women to die from cancer. And they are 16 per cent more likely to develop the disease in the first place.
Men are almost 40 per cent more likely than women to die from cancer, reveals a report published by the National Cancer Intelligence Network (NCIN) and Cancer Research UK together with the Men's Health Forum to mark Men's Health Week.
And they are 16 per cent more likely to develop the disease in the first place.
After excluding breast cancer and cancers specific to one or other sex from the analysis*, the difference is even greater ? with men being almost 70 per cent more likely to die from cancer and over 60 per cent more likely to develop the disease.
A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML).
A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.
A new approach to stimulating immune cells enhances their anticancer activity, resulting in a powerful anti-tumor response in mice.
A new approach to stimulating immune cells enhances their anticancer activity, resulting in a powerful anti-tumor response in mice, according to a study by researchers at the National Cancer Institute, a part of the National Institutes of Health. This work represents an important advance in the development of immunotherapy for cancer and appears online June 14, 2009 in Nature Medicine.
( 28% )
E-Mail Story
Print Story
